Stella Okoli’s Emzor has raised N26.7bn ($19.8m) at a 19% coupon to finish West Africa’s first antimalarial API plant a Sagamu facility that was due to open in late 2025, then early 2026, and is still incomplete. Stella Okoli’s Emzor Pharmaceutical Industries has raised a N26.7 billion ($19.8 million) bond at a 19 percent coupon to complete an antimalarial active pharmaceutical ingredient plant that has now missed two announced start dates. The …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.